SCHEMBL7012000

SCHEMBL7012000

NNC(=O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.72
KDM4E B2RXH2 3/20 0.72
HTT P42858 2/20 0.55
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
GAA P10253 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
F10 P00742 3/20 0.43
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8174639 0.84 ALDH1A1 (1.00) ALDH1A1KDM4ENPC1GAACA12
SCHEMBL7012908 0.82 GAA (0.55) ALDH1A1KDM4EHTTNPC1GAA
SCHEMBL2070301 0.82 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL7017091 0.81 MMP2 (0.49) ALDH1A1KDM4EHTTNPC1GAA
SCHEMBL8283278 0.75 F10 (0.53) ALDH1A1KDM4EHTTNPC1F10
SCHEMBL7598374 0.73 NPC1 (0.47) ALDH1A1NPC1F10POLB
SCHEMBL7009093 0.73 CA2 (0.49) ALDH1A1KDM4EHTTCA2F10
SCHEMBL949128 0.73 F10 (0.54) ALDH1A1KDM4EHTTF10HPGD
SCHEMBL947731 0.73 ALDH1A1 (0.56) ALDH1A1KDM4EHTTF10HPGD
SCHEMBL13263385 0.72 F10 (0.56) NPC1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH ALDH1A1 4317/4885KDM4E 533/4885HTT 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.